serena williams glp-1 medication Opens Up About Being on a Serena Williams comeback has GLP-1

have no conflicts to disclose

Many insurance plans covered compounded tirzepatide during the FDA shortage period but discontinued coverage once the shortage resolved in December 2024

GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) have transformed weight management

A recent meta-analysis demonstrated that SGLT2 inhibitors and glucagon-like 1 receptor agonists (GLP-1RAs) have favorable effects on the cardiorenal outcomes in type 2 diabetes (T2D) ( Therapeutic Targets in Diabetic Kidney Disease DKD is a risk factor for both ESRD and CVD

But as I got older, nothing seemed to work anymore

Blood in your stool or black, tarry stools